2011 was more or less a wash for stock performance when it was all said and done. There were several great stories and there were many duds. 24/7 Wall St. has compiled a list…
Jon OggFinding analyst calls from Wall Street research and brokerage firms on the last trading day of the year is a bit like looking for four-leaf clovers. Still, there are a few analyst upgrades,…
Calling on the death of a company is no fun task. Some companies cannot get it right and it is amazing how some companies can hold on to a status as a public company. …
The December Credit Managers’ Index was released today by the National Association of Credit Management and it showed a 7-month high reading of 54.4. The reading is the highest since May 2011 but is…
The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones Industrial Average components, appears to be undergoing a bit of change for 2012. There…
Diamond Foods, Inc. (NASDAQ: DMND) has seen a reversal of fortune like very few non-biotech and non-online stocks have seen in 2011. From accounting concerns, to troubles with an acquisition, to a director’s suicide. …
Netflix, Inc. (NASDAQ: NFLX) went from Wall Street’s darling in 2011 to being Wall Street’s whipping boy. The company’s efforts under Reed Hastings could easily become the classic case study for “How To Kill…
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) is a year-end winner in small-cap biotech and emerging pharma based upon hepatitis-C Phase II trial data. The preliminary data shows that antiviral activity and a positive safety profile at…
The U.S. Labor Department is out with its reading on weekly jobless claims. After some improvements in the weeks before, the tally of claims rose by 15,000 to 381,000. Bloomberg had estimates at 372,000…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. The number of research calls is dropping significantly and this week is usually…
There are often some very interesting S-1 filings with the SEC, some of which are true initial public offerings and some of which are more or less solicitations to raise private capital. Before you…
TrimTabs is showing what many investors might have expected. After such a volatile year in the stock market, investors are seeking safety in the nearly no-income offered by bond funds and bank savings accounts. The…
Lululemon Athletica Inc. (NASDAQ: LULU) has seen its investor growth prospects dim compared to what we have seen in past quarters. Sales are up huge, but the stock has matured after valuations reached nose-bleed…
It is no secret that Iran is a saber-rattling nation. The country wants to be relevant on the global stage so much that it keeps up with its nuclear ambitions regardless of global trading…
Janney Capital Markets is out with a stark reminder for bulls and bears alike: increased confidence at the end of a year and even at the very start of a year do not translate…
comScore (NASDAQ: SCOR) has released the holiday sales data, showing how online retail yet again grew at a fast pace then traditional brick-and-mortar retail outfits. The holiday season retail e-commerce spending report for the…
Molycorp, Inc. (NYSE: MCP) is being punished today on news which some would argue is very mixed. J.P. Morgan decided to lower its price target and earnings estimates for Molycorp. The new target is…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. As usual for the week between Christmas and New Years, the volume of…
In December you get to see all sorts of predictions and stock picks from market pundits for the year ahead. This year is no different, and Credit Suisse has issued this month its list…
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come from this…